Liquidia (NASDAQ: LQDA) revenue
Liquidia reported revenue of $158.3m for fiscal 2025, 1,031.2% more than in fiscal 2024 ($14.0m). Since fiscal 2019 its revenue has grown by 1,861.3%, an average growth of 64.2% a year.
Fiscal 2025 is the highest of the 7 fiscal years on record for Liquidia. The biggest drop was in fiscal 2020, −90.8%.
Embed this chart
Copy this code into your website or blog. The chart updates with each new annual report.
Revenue by fiscal year
| Fiscal year | Revenue | Change | Operating profit | Operating margin |
|---|---|---|---|---|
| 2025 | $158.3m | +1,031.2% | −$51.4m | −32.5% |
| 2024 | $14.0m | −20.0% | −$121.3m | −866.6% |
| 2023 | $17.5m | +9.7% | −$73.4m | −419.6% |
| 2022 | $15.9m | +24.0% | −$38.8m | −243.3% |
| 2021 | $12.9m | +1,637.8% | −$33.8m | −263.0% |
| 2020 | $0.7m | −90.8% | −$59.1m | −7,989.0% |
| 2019 | $8.1m | — | −$46.8m | −580.1% |
The change compares each fiscal year with the one before. Operating margin is operating profit over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.
Liquidia revenue compared with its sector
By revenue for its latest fiscal year, Liquidia ranks 260th of the 422 US health care companies with a page on Celsmar. The sector median grew 11.7% in its latest fiscal year; Liquidia, 1,031.2%.
| Rank | Company | Revenue | Revenue growth |
|---|---|---|---|
| 258th | Ginkgo Bioworks | $170.2m | −25.1% |
| 259th | Pacific Biosciences of California | $160.0m | 3.9% |
| 260th | Liquidia | $158.3m | 1,031.2% |
| 261st | Heron Therapeutics | $154.9m | 7.4% |
| 262nd | AirSculpt Technologies | $151.8m | −15.8% |
Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.
Questions about the revenue of Liquidia
- How much revenue did Liquidia make in fiscal 2025?
- Liquidia reported revenue of $158.3m for fiscal 2025, compared with $14.0m in fiscal 2024.
- How much has the revenue of Liquidia grown?
- Between fiscal 2019 and fiscal 2025 it went from $8.1m to $158.3m: 1,861.3% more, an average growth of 64.2% a year.
- What was the best year for revenue at Liquidia?
- Of its last 7 fiscal years, fiscal 2025, with $158.3m.
- Where does Liquidia rank in its sector by revenue?
- It ranks 260th of the 422 US health care companies with a page on Celsmar, by revenue for its latest fiscal year.
- Where do the figures for Liquidia come from?
- From the annual report (Form 10-K) that Liquidia files with the SEC, the US securities regulator. Each fiscal year links to its filing.
Where each figure comes from
From the annual report (Form 10-K) that Liquidia files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020 · 2019. More on Liquidia: the Liquidia page · annual accounts · net income · insider transactions.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.